Repligen
RGEN
#2102
Rank
S$11.41 B
Marketcap
S$202.76
Share price
-0.74%
Change (1 day)
-4.98%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): S$31.68 Million

According to Repligen 's latest financial reports the company's current earnings are S$0.70 Billion. In 2024 the company made an earning of -S$8.15 Million a decrease over its 2023 earnings that were of S$62.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$31.68 M-488.93%
2024 -S$8.15 Million-113.01%
2023 S$62.6 M-78.01%
2022 S$0.28 B33.37%
2021 S$0.21 B131.52%
2020 S$92.19 M101.31%
2019 S$45.79 M25.93%
2018 S$36.36 M105.61%
2017 S$17.68 M-11.46%
2016 S$19.97 M14.91%
2015 S$17.38 M20.26%
2014 S$14.45 M-51.49%
2013 S$29.8 M90.98%
2012 S$15.6 M
2010 S$0.22 M-103.81%
2009 -S$5.93 Million-223.84%
2008 S$4.78 M
2006 -S$3.22 Million229.64%
2005 -S$0.98 Million-89.16%
2004 -S$9.01 Million-16.86%
2003 -S$10.83 Million88.72%
2002 -S$5.74 Million-27.88%
2001 -S$7.96 Million-1.74%
2000 -S$8.1 Million85.93%
1999 -S$4.36 Million159.16%
1998 -S$1.68 Million85.71%
1997 -S$0.91 Million-70.83%
1996 -S$3.11 Million-72.41%
1995 -S$11.25 Million-60.63%
1994 -S$28.56 Million45.39%
1993 -S$19.65 Million39.45%
1992 -S$14.09 Million-32.3%
1991 -S$20.81 Million6.62%
1990 -S$19.52 Million1577.78%
1989 -S$1.17 Million-57.14%
1988 -S$2.72 Million-362.5%
1987 S$1.03 M-130.77%
1986 -S$3.36 Million136.36%
1985 -S$1.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novavax
NVAX
S$0.48 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.87 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.75 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$13.25 B 39,143.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$9.16 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.37 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.31 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.14 B 342.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.15 Billion-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-S$28.68 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA